Home » Topics » BioWorld Science

BioWorld Science
RSS

AstraZeneca patents SLC12A5 activators

Oct. 8, 2021

Chronic myeloid leukemia therapy may be enhanced by ULK1 inhibition

Oct. 7, 2021

Amgen and Neumora collaborate in neuropsychiatric and neurodegenerative diseases

Oct. 7, 2021

RAC1 predicts dabrafenib resistance in papillary thyroid cancer

Oct. 7, 2021

Thymosin beta4 reverses cognitive impairment in mouse model of AD

Oct. 7, 2021

THRB agonist reduces aggressive phenotype in anaplastic thyroid cancer

Oct. 7, 2021

VRDN-002 demonstrates promising PK profile in nonhuman primates

Oct. 7, 2021

Study of APOE3 gene variant points to APOE aggregation as a target for treating dementia

Oct. 7, 2021

Verge Analytics discovers new PIKfyve inhibitors

Oct. 7, 2021

Researchers synthesize new CDK inhibitors

Oct. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...